跨导管中侧关闭:一个单一中心的经验,技术和结果
Alev Kılıçgedik1, Büşra Güvendi Şengör2, Ali Karagöz2
1Başakşehir Çam ve Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
Acta cardiologica
|December 14, 2023
概括
传导管中位膜漏洞关闭 (TMPLC) 有效治疗症状膜漏洞 (PVL),改善患者的生存率和生活质量. 这种微创手术为患有假体门并发症的患者提供了安全和成功的选择.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 门更换后的副门泄漏 (PVL) 可以导致显著的发病率和死亡率.
- 症状性PVL通常需要干预以改善患者的治疗结果.
- 过导管技术为PVL管理提供了一种不那么侵入性的方法.
研究的目的:
- 在一个单一的中心评估跨导管中膜膜泄漏关闭 (TMPLC) 的安全性和有效性.
- 评估TMPLC在症状性额头肌PVL的手术成功和临床结果.
- 分析TMPLC对心力衰竭症状,贫血和整体存活率的影响.
主要方法:
- 对接受TMPLC治疗中度至重度的额头肌PVL的患者进行了回顾性观察性研究.
- 由经验丰富的操作人员使用标准化技术执行的程序.
- 数据收集包括程序成功,临床结果和不良事件.
主要成果:
- 在45名患者中,58种缺陷中有91.4%的缺陷成功被封闭.
- 临床成功率为75.6%,喷射分数,血红蛋白显著改善,LDH减少.
- 30天和住院死亡率为8.9%.
结论:
- TMPLC是一种安全有效的治疗症状的额头肌PVL.
- 该程序导致显著的临床改善和降低死亡率.
- 单操作员TMPLC在现实环境中表现出了有利的结果.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


